Sensitivity to triazolam in the elderly

New England Journal of Medicine

Volumn 324, Issue 24, 1991, Pages 1691-1698

  Greenblatt, David J ^a   Harmatz, Jerold S ^a   Shapiro, Lisa ^a   Engelhardt, Nina ^a   Gouthro, Terry A ^a   Shader, Richard I ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRIAZOLAM;

ADULT; AGED; AGING; CONFERENCE PAPER; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG CLEARANCE; DRUG DOSE; DRUG EFFECT; DRUG SENSITIVITY; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; DOUBLE-BLIND METHOD; FEMALE; HUMAN; MALE; MEMORY; MIDDLE AGE; PSYCHOMOTOR PERFORMANCE; SUPPORT, U.S. GOV'T, P.H.S.; TRIAZOLAM;

EID: 0025807082     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199106133242403     Document Type: Article

References (63)

1. Prinz P.N., Vitiello M.V., Raskind M.A., Thorpy M.J. Geriatrics: sleep disorders and aging. N Engl J Med 1990; 323:520-526
2. Morgan K. Hypnotics in the elderly: what cause for concern? Drugs 1990; 40:688-696
3. Shorr R.I., Bauwens S.F., Landefeld C.S. Failure to limit quantities of benzodi-azepine hypnotic drugs for outpatients: placing the elderly at risk. Am J Med 1990; 89:725-732
4. Greenblatt D.J., Divoll M., Harmatz J.S., MacLaughlin D.S., Shader R.I. Kinetics and clinical effects of flurazepam in young and elderly noninsomniacs. Clin Pharmacol Ther 1981; 30:475-486
5. Solomon F., White C.C., Parron D.L., Mendelson W.B. Sleeping pills, insomnia and medical practice. N Engl J Med 1979; 300:803-808
6. Greenblatt D.J., Allen M.D., Shader R.I. Toxicity of high-dose flurazepam in the elderly. Clin Pharmacol Ther 1977; 21:355-361
7. Ray W.A., Griffin M.R., Downey W. Benzodiazepines of long and short elimination half-life and the risk of hip fracture. JAMA 1989; 262:3303-3307
8. Ray W.A., Griffin M.R., Schaffner W., Baugh D.K., Melton L.J. III. Psychotropic drug use and the risk of hip fracture. N Engl J Med 1987; 316:363-369
9. Pakes G.E., Brogden R.N., Heel R.C., Speight T.M., Avery G.S. Triazolam: a review of its pharmacological properties and therapeutic efficacy in patients with insomnia. Drugs 1981; 22:81-110.
10. Roth T., Roehrs T.A., Zorick F.J. Pharmacology and hypnotic efficacy of triazolam. Pharmacotherapy 1983; 3:137-148
11. Ogura C., Nakazawa K., Majima K., et al. Residual effects of hypnotics: triazolam, flurazepam, and nitrazepam. Psychopharmacology (Berlin) 1980; 68:61-65
12. Bliwise D., Seidel W., Karacan I., et al. Daytime sleepiness as a criterion in hypnotic medication trials: comparison of triazolam and flurazepam. Sleep 1983; 6:156-163
13. Cohn J.B. Double-blind crossover comparison of triazolam and lorazepam in the posthypnotic state. J Clin Psychiatry 1984; 45:104-107
14. Carskadon M.A., Seidel W.F., Greenblatt D.J., Dement W.C. Daytime carryover of triazolam and flurazepam in elderly insomniacs. Sleep 1982; 5:361-371
15. Woo E., Proulx S.M., Greenblatt D.J. Differential side effect profile of triazolam versus flurazepam in elderly patients undergoing rehabilitation therapy. J Clin Pharmacol 1991; 31:168-173
16. Greenblatt D.J., Shader R.I., Abernethy D.R. Current status of benzodiazepines. N Engl J Med 1983; 309:354-8, 410-6.
17. Kales A., Soldatos C.R., Bixler E.O., Kales J.D. Rebound insomnia and rebound anxiety: a review. Pharmacology 1983; 26:121-137
18. Kales A., Kales J.D. Sleep laboratory studies of hypnotic drugs: efficacy and withdrawal effects. J Clin Psychopharmacol 1983; 3:140-150
19. Gillin J.C., Spinweber C.L., Johnson L.C. Rebound insomnia: a critical review. J Clin Psychopharmacol 1989; 9:161-172
20. Morgan K., Oswald I. Anxiety caused by a short-life hypnotic. BMJ 1982; 284:942.
21. Adam K., Oswald I. Can a rapidly-eliminated hypnotic cause daytime anxiety? Pharmacopsychiatry 1989; 2:115-119
22. Bliwise D.L., Seidel W.F., Cohen S.A., Bliwise N.G., Dement W.C. Profile of mood states changes during and after 5 weeks of nightly triazolam administration. J Clin Psychiatry 1988; 49:349-355
23. Morris H.H. III, Estes M.L. Traveler#x0027;s amnesia: transient global amnesia secondary to triazolam. JAMA 1987; 258:945-946
24. Patterson J.F. Triazolam syndrome in the elderly. South Med J 1987; 80: 1425-6.
25. Kales A., Bixler E.O., Vela-Bueno A., Soldatos C.R., Nikiaus D.E., Manfredi R.L. Comparison of short and long half-life benzodiazepine hypnotics: triazolam and quazepam. Clin Pharmacol Ther 1986; 40:378-386
26. Griffiths R.R., Lamb R.J., Ator N.A., Roache J.D., Brady J.V. Relative abuse liability of triazolam: experimental assessment in animals and humans. Neurosci Biobehav Rev 1985; 9:133-151
27. Bixler E.O., Kales A., Brubaker B.H., Kales J.D. Adverse reactions to benzodiazepine hypnotics: spontaneous reporting system. Pharmacology 1987; 35: 286-300.
28. Kales A. Benzodiazepine hypnotics and insomnia. Hosp Pract [Off] 1990; 25:Suppl 3:7-21.
29. Greenblatt D.J., Shader R.I., Harmatz J.S. Implications of altered drug disposition in the elderly: studies of benzodiazepines. J Clin Pharmacol 1989; 29:866-872
30. Greenblatt D.J., Divoll M., Abernethy D.R., Moschitto L.J., Smith R.B., Shader R.I. Reduced clearance of triazolam in old age: relation to antipyrine oxidizing capacity. Br J Clin Pharmacol 1983; 15:303-309
31. Smith R.B., Divoll M., Gillespie W.R., Greenblatt D.J. Effect of subject age and gender on the pharmacokinetics of oral triazolam and temazepam. J Clin Psychopharmacol 1983; 3:172-176
32. Giles H.G., MacLeod S.M., Wright J.R., Sellers E.M. Influence of age and previous use on diazepam dosage required for endoscopy. Can Med Assoc J 1978; 118:513-514
33. Reidenberg M.M., Levy M., Warner H., et al. Relationship between diazepam dose, plasma level, age, and central nervous system depression. Clin Pharmacol Ther 1978; 23:371-374
34. Castleden C.M., George C.F., Marcer D., Hallett C. Increased sensitivity to nitrazepam in old age. BMJ 1977; 1:10-12
35. Swift C.G., Ewen J.M., Clarke P., Stevenson I.H. Responsiveness to oral diazepam in the elderly: relationship to total and free plasma concentrations. Br J Clin Pharmacol 1985; 20:111-118
36. Pomara N., Stanley B., Block R., et al. Increased sensitivity of the elderly to the central depressant effects of diazepam. J Clin Psychiatry 1985; 46:185-187
37. Bamhill J.G., Greenblatt D.J., Miller L.G., Gaver A., Harmatz J.S., Shader R.I. Kinetic and dynamic components of increased benzodiazepine sensitivity in aging animals. J Pharmacol Exp Ther 1990; 253:1153-1161
38. Guthrie S., Cooper R.L., Thurman R., Linnoila M. Pharmacodynamics and pharmacokinetics of ethanol, diazepam and pentobarbital in young and aged rats. Pharmacol Toxicol 1987; 61:308-312
39. Komiskey H.L., Rahman A., Mundinder K.L. Aging: changes in a passive-avoidance response with brain levels of temazepam. Pharmacol Biochem Behav 1988; 31:611-615
40. Greenblatt D.J. Analysis of benzodiazepines by electron-capture gas-liquid chromatography. In: Sunshine I, Jatlow PI, eds. Methodology in analytical toxicology. Vol. 2. Boca Raton, Fla.: CRC Press, 1982: 19-24.
41. Greenblatt D.J., Harmatz J.S., Engelhardt N., Shader R.I. Pharmacokinetic determinants of dynamic differences among three benzodiazepine hypnotics: flurazepam, temazepam, and triazolam. Arch Gen Psychiatry 1989; 46:326-332
42. Erratum, Arch Gen Psychiatry 1989; 46:793.
43. Greenblatt D.J., Harmatz J.S., Dorsey C., Shader R.I. Comparative single-dose kinetics and dynamics of lorazepam, alprazolam, prazepam, and placebo. Clin Pharmacol Ther 1988; 44:326-334
44. Lapierre K.A., Greenblatt D.J., Goddard J.E., Harmatz J.S., Shader R.I. The neuropsychiatric effects of aspartame in normal volunteers. J Clin Pharmacol 1990; 30:454-460
45. Greenblatt D.J., Harmatz J.S., Zinny M.A., Shader R.I. Effect of gradual withdrawal on the rebound sleep disorder after discontinuation of triazolam. N Engl J Med 1987; 317:722-728
46. Shader R.I., Dreyfuss D., Gerrein J.R., Harmatz J.S., Allison S.J., Greenblatt D.J. Sedative effects and impaired learning and recall after single oral doses of lorazepam. Clin Pharmacol Ther 1986; 39:526-529
47. Greenblatt D.J., Divoll M., Moschitto L.I., Shader R.I. Electron-capture gas Chromatographic analysis of the triazolobenzodiazepines alprazolam and triazolam. J Chromatogr 1981; 225:202-207
48. Scavone J.M., Greenblatt D.J., Friedman H., Shader R.I. Enhanced bioavailability of triazolam following sublingual versus oral administration. J Clin Pharmacol 1986; 26:208-210
49. Moschitto L.J., Greenblatt D.J. Concentration-independent plasma protein binding of benzodiazepines. J Pharm Pharmacol 1983; 35:179-180
50. Ochs H.R., Greenblatt D.J., Burstein E.S. Lack of influence of cigarette smoking on triazolam pharmacokinetics. Br J Clin Pharmacol 1987; 23: 759-63.
51. Wilkinson G.R. Clearance approaches in pharmacology. Pharmacol Rev 1987; 39:1-47.
52. Abernethy D.R., Greenblatt D.J., Divoll M., Moschitto L.J., Harmatz J.S., Shader R.I. Interaction of cimetidine with the triazolobenzodiazepines alprazolam and triazolam. Psychopharmacology (Berlin) 1983; 80:275-278
53. Friedman H., Greenblatt D.J., Burstein E.S., Scavone J.M., Harmatz J.S., Shader R.I. Triazolam kinetics: interaction with cimetidine, propranolol, and the combination. J Clin Pharmacol 1988; 28:228-233
54. Miller L.G., Greenblatt D.J., Barnhill J.G., Deutsch S.I., Shader R.I., Paul S.M. Benzodiazepine receptor binding of triazolobenzodiazepines in vivo: increased receptor number with low-dose alprazolam. J Neurochem 1987; 39:1595-1601
55. Scavone J.M., Friedman H., Greenblatt D.J., Shader R.I. Effect of age, body composition, and lipid solubility on benzodiazepine tissue distribution in rats. Arzneimittelforschung 1987; 37:2-6.
56. Nikaido A.M., Ellinwood E.H., Heatherly D.G., Gupta S.K. Age-related increase in CNS sensitivity to benzodiazepines as assessed by task difficulty. Psychopharmacology (Berlin) 1990; 100:90-97
57. Hinrichs J.V., Ghoneim M.M. Diazepam, behavior, and aging: increased sensitivity or lower baseline performance? Psychopharmacology (Berlin) 1987; 92:100-105
58. Wainer H. Adjusting for differential base rates: Lord#x0027;s Paradox again. Psychol Bull 1991; 109:147-151
59. Lister R.G. The amnesic action of benzodiazepines in man. Neurosci Biobehav Rev 1985; 9:87-94.
60. Romney D.M., Angus W.R. A brief review of the effects of diazepam on memory. Psychopharmacol Bull 1984; 20:313-316
61. Ghoneim M.M., Mewaldt S.P. Benzodiazepines and human memory: a review. Anesthesiology 1990; 72:926-938
62. Pomara N., Deptula D., Medel M., Block R.I., Greenblatt D.J. Effects of diazepam on recall memory: relationship to aging, dose, and duration of treatment. Psychopharmacol Bull 1989; 25:144-148
63. Roehrs T., Zorick F., Wittig R., Roth T. Efficacy of a reduced triazolam dose in elderly insomniacs. Neurobiol Aging 1985; 6:293-296